Bevacizumab plus irinotecan in recurrent or progressive malign glioma: a multicenter study of the Anatolian Society of Medical Oncology (ASMO)

被引：0
|
作者：
Umut Demirci
Gulnihal Tufan
Bilge Aktas
Ozan Balakan
Ahmet Alacacioglu
Faysal Dane
Huseyin Engin
M. Ali Kaplan
Yusuf Gunaydin
Nuriye Y. Ozdemir
I. Tugba Unek
Halit Karaca
Tulay Akman
Ozlem U. Sonmez
Ugur Coskun
Hakan Harputluoglu
Alper Sevinc
Onder Tonyali
Suleyman Buyukberber
Mustafa Benekli
机构：
[1] Ataturk Training and Research Hospital,Department of Medical Oncology
[2] Gazi University Faculty of Medicine,Department of Medical Oncology
[3] Marmara University Faculty of Medicine,Department of Medical Oncology
[4] Gaziantep University Faculty of Medicine,Department of Medical Oncology
[5] Katip Celebi University Faculty of Medicine,Department of Medical Oncology
[6] Zonguldak Bulent Ecevit University Faculty of Medicine,Department of Medical Oncology
[7] Dicle University Faculty of Medicine,Department of Medical Oncology
[8] Numune Training and Research Hospital,Department of Medical Oncology
[9] Tepecik Training and Research Hospital,Department of Medical Oncology
[10] Erciyes University Faculty of Medicine,Department of Medical Oncology
[11] Dokuz Eylul University Faculty of Medicine,Department of Medical Oncology
[12] Sakarya Training and Research Hospital,Department of Medical Oncology
[13] Inönü University Faculty of Medicine,Department of Medical Oncology
[14] Antakya State Hospital,Department of Medical Oncology
来源：
Journal of Cancer Research and Clinical Oncology | 2013年 / 139卷
关键词：
Bevacizumab; Irinotecan; Recurrent disease; Malignant glioma;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：829 / 835
页数：6
相关论文
共 50 条
  • [1] Bevacizumab plus irinotecan in recurrent or progressive malign glioma: a multicenter study of the Anatolian Society of Medical Oncology (ASMO)
    Demirci, Umut
    Tufan, Gulnihal
    Aktas, Bilge
    Balakan, Ozan
    Alacacioglu, Ahmet
    Dane, Faysal
    Engin, Huseyin
    Kaplan, M. Ali
    Gunaydin, Yusuf
    Ozdemir, Nuriye Y.
    Unek, I. Tugba
    Karaca, Halit
    Akman, Tulay
    Sonmez, Ozlem U.
    Coskun, Ugur
    Harputluoglu, Hakan
    Sevinc, Alper
    Tonyali, Onder
    Buyukberber, Suleyman
    Benekli, Mustafa
    [J]. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2013, 139 (05) : 829 - 835
  • [2] Multicenter experience of adult medulloblastoma: A study of Anatolian Society of Medical Oncology (ASMO)
    Esbah, Onur
    Demirci, Umut
    Dane, Faysal
    Gunaydsin, Yusuf
    Ozdemir, Nuriye
    Ekinci, Ahmet Siyar
    Kodaz, Hilmi
    Yazilitas, Dogan
    Rzayev, Rashad
    Guney, Yildiz
    Seker, Metin
    Uysal, Mukremin
    Inal, Ali
    Bilici, Ahmet
    Benekli, Mustafa
    Oksuzoglu, Berna
    Buyukberber, Suleyman
    [J]. JOURNAL OF BUON, 2016, 21 (02): : 456 - 460
  • [3] EFFICACY OF BEVACIZUMAB PLUS IRINOTECAN IN CHILDREN WITH RECURRENT OR PROGRESSIVE MALIGNANT GLIOMA
    Arakawa, Yoshiki
    Umeda, Katsutsugu
    Watanabe, Ken-ichiro
    Mizowaki, Takashi
    Hiraoka, Masahiro
    Hiramatsu, Hidefumi
    Adachi, Souichi
    Kunieda, Takeharu
    Takagi, Yasushi
    Miyamoto, Susumu
    [J]. NEURO-ONCOLOGY, 2014, 16 : 59 - 59
  • [4] The role of the gastrectomy on survival in metastatic gastric cancer patients: A multicenter study of Anatolian Society of Medical Oncology (ASMO)
    Yazici, Ozan
    Ozdemir, Nuriye
    Duran, Ayse Ocak
    Menekse, Serkan
    Sendur, Mehmet Ali Nahit
    Karaca, Halit
    Goksel, Gamze
    Arpaci, Erkan
    Eren, Tulay
    Hacibekiroglu, Ilhan
    Bilgetekin, Irem
    Kacan, Turgut
    Ozkan, Metin
    Aksoy, Sercan
    Aksoy, Asude
    Zengin, Nurullah
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [5] Lapatinib plus capecitabine for HER2-positive advanced breast cancer: a multicentre study of Anatolian Society of Medical Oncology (ASMO)
    Cetin, Bulent
    Benekli, Mustafa
    Turker, Ibrahim
    Koral, Lokman
    Ulas, Arife
    Dane, Faysal
    Oksuzoglu, Berna
    Kaplan, Mehmet Ali
    Koca, Dogan
    Boruban, Cem
    Yilmaz, Burcak
    Sevinc, Alper
    Berk, Veli
    Uncu, Dogan
    Harputluoglu, Hakan
    Coskun, Ugur
    Buyukberber, Suleyman
    [J]. JOURNAL OF CHEMOTHERAPY, 2014, 26 (05) : 300 - 305
  • [6] Clinicopathologic characteristics, treatment outcomes, and prognostic factors of primary thoracic soft tissue sarcoma: A multicenter study of the Anatolian Society of Medical Oncology (ASMO)
    Unal, Olcun Umit
    Oztop, Ilhan
    Yasar, Nurgul
    Urakci, Zuhat
    Ozatli, Tahsin
    Bozkurt, Oktay
    Sevinc, Alper
    Gunaydin, Yusuf
    Taskoylu, Burcu Yapar
    Arpaci, Erkan
    Ulas, Arife
    Kodaz, Hilmi
    Tonyali, Onder
    Avci, Nilufer
    Aksoy, Asude
    Yilmaz, Ahmet Ugur
    [J]. THORACIC CANCER, 2015, 6 (01) : 85 - 90
  • [7] Bevacizumab plus irinotecan in the treatment patients with progressive recurrent malignant brain tumours
    Poulsen, Hans Skovgaard
    Grunnet, Kirsten
    Sorensen, Morten
    Olsen, Preben
    Hasselbalch, Benedikte
    Nelausen, Knud
    Kosteljanetz, Michael
    Lassen, Ulrik
    [J]. ACTA ONCOLOGICA, 2009, 48 (01) : 52 - 58
  • [8] XELOX Plus Bevacizumab vs. FOLFIRI Plus Bevacizumab Treatment for First-line Chemotherapy in Metastatic Colon Cancer: a Retrospective Study of the Anatolian Society of Medical Oncology
    Duran, Ayse Ocak
    Karaca, Halit
    Besiroglu, Mehmet
    Bayoglu, Ibrahim Vedat
    Menekse, Serkan
    Yapici, Heves Surmeli
    Yazilitas, Dogan
    Bahceci, Aykut
    Uysal, Mukremin
    Sevinc, Alper
    Hacibekiroglu, Ilhan
    Aksoy, Asude
    Tanriverdi, Ozgur
    Arpaci, Erkan
    Inanc, Mevlude
    Dane, Faysal
    Ozkan, Metin
    [J]. ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2014, 15 (23) : 10375 - 10379
  • [9] Prognostic Factors and Adjuvant Treatments for Surgically Treated Cancers of the Biliary Tract: A Multicentre Study of the Anatolian Society of Medical Oncology (ASMO)
    Unal, Olcun Umit
    Oztop, Ilhan
    Kos, Tugba
    Turan, Nedim
    Kucukoner, Mehmet
    Helvaci, Kaan
    Berk, Veli
    Sevinc, Alper
    Yildiz, Ramazan
    Cinkir, Havva Yesil
    Tonyali, Onder
    Demirci, Umut
    Aktas, Bilge
    Balakan, Ozan
    Yilmaz, Ahmet Ugur
    [J]. ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2014, 15 (22) : 9687 - 9692
  • [10] Efficacy and tolerability of first-line chemotherapy in elderly patients ( age ≥70 years) with metastatic gastric cancer: a multicenter study of the Anatolian Society of Medical Oncology (ASMO)
    Aldemir, M. N.
    Turkeli, M.
    Hacioglu, B.
    Sakin, A.
    Yaman, E.
    Coban, E.
    Koca, D.
    Karaca, M.
    Simsek, M.
    Bahceci, A.
    Sen, E.
    Eren, T.
    Aliustaoglu, B. O.
    Sakalar, T.
    Kalkan, N. O.
    Aktas, G.
    Bilici, M.
    Turhal, S.
    Benekli, M.
    Tekin, S. B.
    [J]. ANNALS OF ONCOLOGY, 2016, 27
12345